Showing results (181-190 of 188) with videos related to
Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 188 results.
Mucosal Immunology|December 11, 2014
PTPN2 controls differentiation of CD4⁺ T cells and limits intestinal inflammation and intestinal dysbiosisM R Spalinger, S Kasper, C Chassard, et al.International Journal of Immunogenetics|November 4, 2008
The role of genetic variants of NOD2/CARD15, a receptor of the innate immune system, in GvHD and complications following related and unrelated donor haematopoietic stem cell transplantationE Holler, G Rogler, J Brenmoehl, et al.Alimentary Pharmacology & Therapeutics|May 15, 2015
Deviations in human gut microbiota: a novel diagnostic test for determining dysbiosis in patients with IBS or IBDC Casén, H C Vebø, M Sekelja, et al.Alimentary Pharmacology & Therapeutics|October 21, 2017
Genetic polymorphisms associated with smoking behaviour predict the risk of surgery in patients with Crohn's diseaseB M Lang, L Biedermann, W T van Haaften, et al.Mucosal Immunology|October 17, 2013
Aluminum enhances inflammation and decreases mucosal healing in experimental colitis in miceG Pineton de Chambrun, M Body-Malapel, I Frey-Wagner, et al.Journal of Crohn'S & Colitis|June 21, 2019
The Oxysterol Synthesising Enzyme CH25H Contributes to the Development of Intestinal FibrosisT Raselli, A Wyss, M N Gonzalez Alvarado, et al.Alimentary Pharmacology & Therapeutics|June 20, 2018
An expert consensus to standardise definitions, diagnosis and treatment targets for anti-fibrotic stricture therapies in Crohn's diseaseF Rieder, D Bettenworth, C Ma, et al.Journal of Crohn'S & Colitis|April 16, 2013
Imaging techniques for assessment of inflammatory bowel disease: joint ECCO and ESGAR evidence-based consensus guidelinesJ Panes, Y Bouhnik, W Reinisch, et al.Pageof 19